Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer
- PMID: 2828434
- PMCID: PMC1141279
- DOI: 10.1136/jcp.40.12.1432
Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer
Abstract
In 65 patients with primary invasive ductal breast carcinoma the relation between classic prognosticators describing the extent of disease (lymph node metastases and tumour size) and newer promising morphometric and DNA flow cytometric prognostic factors was studied. There was no relation between DNA ploidy, lymph node state, and tumour size. Tumours with a mitotic activity index of more than 10 were predominantly DNA aneuploid (61%) compared with those with a mitotic activity index of less than 10 which showed a DNA aneuploid pattern in 27%. The strongest prognosticator, the morphometric prognostic index (a multivariate combination of mitotic activity index, tumour size, and lymph node state) correlated positively with the DNA index in 63% of the cases (p = 0.038). Thus there was a discrepancy between the morphometric and DNA flow cytometric prognostic variables in 37% of the cases. These results indicate that morphometric and flow cytometric analysis may provide additional information on the prognosis in primary breast cancer.
Similar articles
-
Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.Int J Cancer. 1991 May 10;48(2):173-81. doi: 10.1002/ijc.2910480204. Int J Cancer. 1991. PMID: 2019464
-
Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.Cancer. 1996 Jun 1;77(11):2258-66. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2258::AID-CNCR12>3.0.CO;2-W. Cancer. 1996. PMID: 8635093
-
Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.Lab Invest. 1991 Feb;64(2):215-23. Lab Invest. 1991. PMID: 1671789
-
Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.Pathol Annu. 1990;25 Pt 1:171-210. Pathol Annu. 1990. PMID: 2153277 Review.
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
Cited by
-
Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.Breast Cancer Res Treat. 1991 Sep;19(1):23-31. doi: 10.1007/BF01975201. Breast Cancer Res Treat. 1991. PMID: 1661623
-
Screen-detected breast cancers have a lower mitotic activity index.Br J Cancer. 2000 Jan;82(2):381-4. doi: 10.1054/bjoc.1999.0930. Br J Cancer. 2000. PMID: 10646892 Free PMC article.
-
At convenience and systematic random sampling: effects on the prognostic value of nuclear area assessments in breast cancer patients.Breast Cancer Res Treat. 1995;36(1):55-60. doi: 10.1007/BF00690185. Breast Cancer Res Treat. 1995. PMID: 7579507 Clinical Trial.
-
A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer.Surg Today. 1993;23(7):573-9. doi: 10.1007/BF00311903. Surg Today. 1993. PMID: 8103689
-
The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.Surg Today. 1992;22(3):213-20. doi: 10.1007/BF00308825. Surg Today. 1992. PMID: 1392324
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical